On January 10, 2024, 22-year-old Cole Schmidtknecht of Appleton, Wisconsin, went to his big-box pharmacy and was told that a preventative asthma inhaler he had relied on for years was no longer covered by his insurer.

A lawsuit filed against GoodRx earlier this year alleges that the company is orchestrating an illegal price-fixing scheme with major pharmacy benefit managers that artificially suppresses reimbursement rates paid to independent pharmacies for generic drugs.